iWorx Introduces a New Family of Physiology Teaching Kits for College-Level Labs

Posted on by

Dover, NH (PRWEB) July 24, 2013

iWorx Systems Inc., a developer of advanced physiology teaching solutions, has introduced its new suite of TA Teaching Kits (http://www.iworx.com/teaching-landing/) that include software, components and courseware for performing hundreds of college-level human, animal and plant physiology lab experiments. At the heart of the new kits is the TA Control Module (http://www.iworx.com/products/data-recorders/ix-ta-teaching-assistant-control-module/), which removes many of the tedious set-up and calibration routines typically required to perform a lab. The TA module also incorporates proprietary iWire serial interface technology that enables plug and play expandability to easily enhance course curriculum.

iWorx TA Kits are configured for teaching human, animal, exercise, and psychological physiology, general biology and neurobiology. The all inclusive kits are complemented by easy-to-use LabScribe software that is synced to more than 350 professionally developed lab exercises. The TA control module is easy to use, providing pre-calibrated, plug and play blood pressure, spirometer, and temperature sensors that speed up lab set-up and ensures more lab teaching time. A spirometer, blood pressure sensor, grip force sensor, temperature sensor, pressure sensor and software-controlled high and low voltage stimulators are built-in to the module and ensure consistent performance from lab to lab.

Integral iWire serial interface technology enables plug and play expandability of the TA control module. With two iWire inputs, the TA module can simultaneously record from multiple iWire-compatible sensors via a single connection without requiring additional channels. For example, 12 leads of ECG can be recorded through a single iWire input while traditional recorders would require 12 additional recording channels. iWorx offers a number of iWire compatible sensors for recording ECG, EMG, EEG and GSR signals as well as pulse oximetry and plethysmography.

More information on iWorx TA Teaching Kits can be found at http://www.iworx.com. Contact iWorx Systems, Inc., 62 Littleworth Road, Dover, NH 03820 (T) (800) 234-1757, (F) (603) 742-2455.

Download a high resolution image for print at http://www.iworx.com/wp-content/uploads/2013/07/AHK-TA-2-NR.jpg.

About iWorx

iWorx Systems, Inc. provides a full range of advanced hardware and software tools for physiology teaching and research. iWorx TA Kits include all software, professionally developed courseware, and instrumentation for teaching college level labs in human, animal, exercise and psychological physiology, neurobiology, and plant biology.

See more here:
iWorx Introduces a New Family of Physiology Teaching Kits for College-Level Labs

Fred Grimm: Focus on pro baseball ignores real doping crime: Kids on steroids

Posted on by

In a considerable mischaracterization, the Biogenesis scandal has been painted as an outrage against the integrity of Major League Baseball. Were told to revile the now-defunct anti-aging clinic in Coral Gables because it tempted sports heroes with performance-enhancing drugs and further sullied the reputation of the corporate conglomerate formerly known as Americas pastime.

Biogenesis not only implicated the likes of the Yankees Alex Rodriguez and the Brewers Ryan Braun along with 18 other professional baseball players in its doping racket, but to our collective horror did it after baseball Commissioner Bud Selig had declared doping virtually nonexistent and clearly a thing of the past.

Revelations seeping out of Biogenesis showed Selig to be a fool. And Major League Baseball, in league with the nations sportswriters, went after the players with such a fury that no one much noticed the real crimes perpetrated down at 1390 South Dixie Highway. Not even the Miami-Dade state attorneys office. Not even the local cops.

According to whistleblower Porter Fischer, Biogenesis of America was doping children. Injecting high school kids with illegal and dangerous amalgamations of anabolic steroids and human growth hormones. Along with professional and college athletes, the patient list at the storefront clinic included Miami-Dade high school ball players, come to emulate their pro heroes and cheat their way to stardom.

That should have been cause for outrage. But as Miami Herald reporter Julie Brown reported last week, these felonies were simply shrugged off by local law enforcement. Brown interviewed Fischer, the former employee and investor in Biogenesis turned whistleblower who, armed with incriminating documents filched from the clinic, ignited this latest pro baseball scandal.

But Fischer also offered up evidence of criminal medical procedures involving children. He told Brown that he had notified authorities that young athletes, mostly baseball players, from Gulliver, Columbus, St. Brendan, South Miami and other South Florida high schools had also been juiced at Biogenesis by Anthony Bosch, the clinics counterfeit doctor, who prescribed his pharmaceutical concoctions without the bother of a medical degree.

You want the stuff of outrage? Consider this quote from Fischers lawyer: I dont know why law enforcement hasnt gotten involved, to be honest, Raymond Rafool told Brown. We really cant figure it out. Porter is very upset. Youre talking about high school kids getting this stuff from this clinic. For kids who havent even given their bodies the opportunity to grow to be doing this was really disturbing to him.

Disturbing to him. Not to law enforcement. Not to the Miami-Dade state attorney.

Bosch got off with a $5,000 fine for practicing medicine without a license, levied by the Florida Department of Health pocket change in the highly profitable, ethically bankrupt world of anti-aging clinics.

Why no interest from local cops? Probably because the client list, as Brown reported, also included local cops (along with some lawyers and at least one judge.) It would be like expecting elementary schoolchildren to shut down Cold Stone Creamery.

See more here:
Fred Grimm: Focus on pro baseball ignores real doping crime: Kids on steroids

Environmental Testing by Chennai Testing Laboratory Private Limited, Chennai – Video

Posted on by


Environmental Testing by Chennai Testing Laboratory Private Limited, Chennai
Welcome to Amba Recycler Private Limited, Offer Environmental Monitoring and Assessment Services. Established in 1984 at Chennai, we are an ISO 9001 2008, BI...

By: Abhishek Bhartia

Read the original post:
Environmental Testing by Chennai Testing Laboratory Private Limited, Chennai - Video

A-Rod doctor Michael L. Gross in eye of the storm

Posted on by

FILE PHOTO

Alex Rodriguez

Dr. Michael L. Gross, whose review of Alex Rodriguezs MRI put him at the center of a media maelstrom this week, was reprimanded by the New Jersey licensing board in February for violations at a Hackensack wellness center where he serves as medical director.

He paid a $30,000 fine plus $10,000 in expenses and agreed to take two courses, one on ethics and the other on "blood analyses and physical examinations," records show.

While a serious penalty, the discipline stopped far short of a license suspension. The consent order avoided further proceedings.

The Bergen County orthopedist, 56, told his office Thursday that he was "shutting down interviews," said Lisamarie Volino, the practice manager at the Active Center for Health & Wellness, across the street from Hackensack University Medical Center. She said she had taken about "a hundred calls" since Gross did a radio interview Wednesday saying that he saw no sign of significant injury in the MRI of the Yankees stars left quadriceps.

Gross, who has practiced in Bergen County since 1989, is chief of the sports medicine division at the medical center, but his comments did not represent that institution, said hospital spokeswoman Nancy Radwin.

Gross said Wednesday that Rodriguez was not his patient and had not received treatment at his wellness center. He did not physically examine the third baseman before offering his opinion, at Rodriguezs request.

The formal reprimand was for "failing to adequately ensure proper patient treatment involving the prescribing of hormones including steroids, at Active Health & Wellness Center," according to the states four-page document, signed by Gross and his attorney, Keith J. Roberts, as well as board president George J. Scott.

Gross had hired a practitioner who had completed medical school but did not have a license to practice medicine, the board said, adding that Gross failed to supervise patient care adequately. That practitioner went over blood test results with some patients, the doctor said in interviews.

See original here:
A-Rod doctor Michael L. Gross in eye of the storm

LifeMap Sciences Announces Release of LifeMap Discovery™ Version 1.2 With Extensive Stem Cell Therapy Data

Posted on by

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. announced today the release of LifeMap Discovery version 1.2 (discovery.lifemapsc.com). LifeMap Discovery is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology and disease mechanisms and etiology.

LifeMap Discovery version 1.2 provides enhanced features related to stem cell therapeutic development

LifeMap Discovery is a key component in LifeMaps integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards, the leading human gene database, and MalaCards, the human disease database.

LifeMap Discovery version 1.2 new features and information include the following:

LifeMap Discovery version 1.2 provides enhanced features related to stem cell therapeutic development, said Ronit Shtrichman, Ph.D., MBA, Vice President of Biology at LifeMap Sciences. This version includes substantially upgraded information about stem cells with potential therapeutic applications and stem cell differentiation protocols. It also enables researchers to identify genes specifically expressed during embryonic development and stem cells differentiation, providing the means to generate desired cell types for therapeutic applications.

The extensive coverage of the stem cell therapy pipeline and high throughput gene expression data are significant steps forward in developing our premium model, and are of significant interest to companies developing cell-based therapies. Coupled with the commercial offering of recombinant proteins and PureStem progenitors, it is an important milestone for commercialization of the LifeMap Discovery platform, stated Yaron Guan-Golan, Head of Marketing at LifeMap Sciences.

About LifeMap Sciences, Inc.

LifeMap Sciences (www.lifemapsc.com) core technology and business is based on the LifeMap Integrated Biomedical Knowledgebase, the discovery platform for biomedical and stem cell research. This web-based platform includes GeneCards, the leading human gene compendium; LifeMap Discovery, the embryonic development, stem cell research and regenerative medicine compendium; and MalaCards, the human disease compendium. According to Google Analytics, the sites have generated more than 2,000,000 unique visitors with more than 13,000,000 page views, from more than 3,000 universities, institutions and biomedical companies in the past 12 months.

Via LifeMap BioReagents, LifeMap offers leading edge reagents to researchers in academia, research hospitals, and biotech and pharma companies. LifeMap is BioTimes principal marketing subsidiary for research products, including PureStem human progenitor cells, PureStem packages, clinical and research grade human embryonic stem cell (hES) lines, culture media, and cell differentiation kits. The eCommerce portal also offers select recombinant proteins, including growth factors, signaling molecules, differentiation factors, cytokines and chemokines that complement BioTimeresearch product lines.

In therapeutic discovery collaboration with BioTime, LifeMaps scientists utilize the Integrated Biomedical Knowledgebase to aid in the development of BioTimes proprietary library of more than 200 PureStem human progenitor cell types into products for the treatment of human diseases, especially degenerative diseases that might be treatable with cell replacement therapies. A bioinformatics platform developed by LifeMap is used to select the PureStem cells that are most likely to be useful in developing cell-based regenerative medicine therapies for a wide range of diseases.

Read the original:
LifeMap Sciences Announces Release of LifeMap Discovery™ Version 1.2 With Extensive Stem Cell Therapy Data

Listeria Monocytogenes PCR Assay Offers Validated Method for Fast, Simple Detection of Food Pathogens

Posted on by

AOAC-RI Performance Tested Method status granted for the SureTect Listeria monocytogenes Assay

BASINGSTOKE, United Kingdom--(BUSINESS WIRE)--Food microbiology laboratories can now confidently test to a recognized standard for Listeria monocytogenes with the Thermo Scientific SureTect Listeria monocytogenes Assay, which has been granted Performance Tested MethodSM status by the AOAC Research Institute.

We are delighted to have received validation of our Listeria monocytogenes PCR assay, which is one of a number of assays we offer for molecular food testing

Listeria monocytogenes can be present in a variety of foodstuffs, including some processed meats and cheeses, and in fresh foods such as cantaloupe melon and raw spinach.

The SureTect Listeria monocytogenes PCR Assay has proven to be comparable to the reference method ISO 11290-1:1996, including Amendment 1:2004 (Listeria monocytogenes). This follows the recent granting of AOAC-RI Performance Method status for the SureTect Salmonella species PCR Assay.

We are delighted to have received validation of our Listeria monocytogenes PCR assay, which is one of a number of assays we offer for molecular food testing, says Sumi Thaker, VP Global Marketing, Microbiology, Thermo Fisher Scientific. These assays are part of the SureTect Real-Time PCR System that has been designed to streamline test workflow and reduce time to result, which are primary considerations in todays pathogen test selection. We anticipate validation on a number of new assays over the next few months.

The SureTect System was developed to detect microorganisms quickly and accurately in a broad range of foods and associated samples. This unique solution combines:

For more information, please contact your local Thermo Scientific representative or visit http://www.thermoscientific.com/SureTect.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit http://www.thermofisher.com.

Read more here:
Listeria Monocytogenes PCR Assay Offers Validated Method for Fast, Simple Detection of Food Pathogens